To The Moon

$Palantir Technologies Inc.(PLTR)$ its a tricky one. I missed the boat completely and only got in at $69, after I kinda figured them out enough. Alex hasnt really impressed me in his speechs, does not really explain things clearly. He is obviously brilliant, but you can't be good at everything i guess. His writings are a totally different story, clear and concise.  Can palantir go to $150? I'll reserve my opinion until i read his upcoming book. But i will slowly add to my position on dips. Im sure there will be some downward pressure at some points. I think institutional investors are kicking themselves and will try to push the price down to buy it. But there is no way im selling. This is a ten year plus hold and accumulate. The TTM P/E

You could have lived the dream life—retiring early, indulging in eating, sleeping, hitting the gym, enjoying buffets, and shopping—all thanks to investing in the undiscovered gem, Palantir Technologies, at the beginning of last year. I missed the rally... [Facepalm]  $Palantir Technologies Inc.(PLTR)$  is absolutely killing it! Their AI strategy has propelled their performance to new heights, with their stock skyrocketing by 18% pre market.  Letter to Shareholders February 3, 2025 We are still in the earliest stages, the beginning of the first act, of a revolution that will play out over years and decades. Palantir delivered a mind-blowing Q4 2024 earnings report, smashing market expectations and

1. Stock Market Volatility as Tariff Deadline Shifts Markets swung sharply on Monday as investors reacted to shifting White House signals on trade policy. The Dow Jones Industrial Average ended down 123 points (-0.3%), the $.SPX(.SPX)$ fell 0.8%, and the $.IXIC(.IXIC)$ dropped 1.2% $NVIDIA(NVDA)$ $Tesla Motors(TSLA)$ . The Dow had been down over 600 points earlier in the day before rebounding on signs of flexibility from the White House. Tariffs Sectors hardest hit: Automakers & Auto Parts: Potential supply chain disruptions Beer Importers: Higher costs on key imports from Mexico and Canada 2. A Temporary Tariff Re

$MicroStrategy(MSTR)$ is scheduled to report the fourth-quarter earnings for 2024 on 05 Feb 2025 after market close. If we looked at how MSTR have performance in its previous few quarter, the third-quarter did show some strong cloud revenue growth in non-GAAP subscription billings grew 93% year-over-year to $32.4 million, with strong demand for cloud offerings. And there is also success in its convertible bond strategy which have outperformed bitcoin, providing investors with a favorable return. MSTR’s bitcoin holdings stood at 471,107 bitcoins as of 02 Feb, unchanged from the prior week, based on company filings with the Securities and Exchange Commission. But question remain whether MSTR could keep its cloud subscription billings high as analyst

The rapid advancement of quantum computing has prompted a significant shift towards post-quantum cryptography (PQC) to safeguard data against potential quantum attacks. This article delves into the fundamentals of PQC, its current applications, challenges, and future outlook. 1. Understanding Post-Quantum Cryptography 🔐 Defining Post-Quantum Cryptography Post-quantum cryptography encompasses cryptographic algorithms designed to remain secure against the computational capabilities of quantum computers. Unlike traditional cryptographic methods, PQC aims to protect data from being deciphered by quantum algorithms, such as Shor's algorithm, which can efficiently solve problems that are currently intractable for classical computers. 🔑 Key Characteristics Quantum Resistance: Algorithms are devel

$Merck(MRK)$ Starting with Merck & Co., the stock is down approximately 10% shortly after the market opened. Over the past year, the company has performed poorly, with a negative return of 29%. Even over the past decade, its 52% gain has underperformed the S&P 500. Currently, the stock is trading at a new 52-week low. However, Seeking Alpha has rated it as a strong buy, and Wall Street analysts also consider it a buy. Additionally, Merck offers a dividend yield exceeding 3%, making it an attractive option for income-focused investors. primarily due to challenges with its Gardasil vaccine and a conservative 2025 financial outlook. Merck the decision to halt Gardasil shipments to China. This move aimed to allow a local partner to reduce exces